You are viewing: UK ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The UK ECMO Machines Market was valued at $18.84 Million in 2025 and projected to reach to $24.96 Million by 2030, representing a compound annual growth rate of 5.8%. The UK ECMO machines market is poised for steady growth driven by increasing recognition of extracorporeal membrane oxygenation as a critical intervention in severe respiratory and cardiac failure cases.

UK ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK ECMO Machines Market Trends and Insights

  • The UK market reflects steady demand driven by increasing adoption of extracorporeal membrane oxygenation technology in critical care settings across NHS hospitals and private healthcare facilities.
  • The UK's advanced healthcare infrastructure and emphasis on cardiac and respiratory support therapies continue to support market expansion through the forecast period. Key drivers of growth in the UK include rising prevalence of cardiac and respiratory conditions, technological advancements in ECMO systems, and increased investment in intensive care unit capabilities.
  • The UK market benefits from strong regulatory frameworks and reimbursement pathways that facilitate adoption of life-support technologies.
  • Between 2025 and 2030, the UK is expected to see enhanced clinical utilization and expanded access to ECMO therapy across major teaching hospitals and regional cardiac centers..

Key Market Statistics

  • CAGR (2025-2030) 5.8% CAGR
  • Market Size, 2025 ~USD 18.84 Million
  • Forecast, 2030 ~USD 24.96 Million
  • Country UK

UK ECMO Machines Market Overview

Market Valuation :

The UK ECMO machines market is valued at $18.84 million in 2025, with a projected value of $24.96 million by 2030, representing a steady 5.8% CAGR over the forecast period.

NHS Adoption Growth :

Increasing integration of ECMO technology across NHS critical care units is driving market expansion, with major teaching hospitals and regional centres expanding their extracorporeal support capabilities.

Private Healthcare Expansion :

UK private healthcare facilities are investing in ECMO infrastructure to enhance their critical care offerings, creating additional demand beyond the NHS sector.

Advanced Healthcare Infrastructure :

The UK's robust healthcare infrastructure and regulatory framework support the adoption of advanced ECMO technologies, positioning the market for sustained growth through 2030.

UK ECMO Machines Market Dynamics

  • NHS trusts are progressively establishing and expanding ECMO centres, supported by clinical guidelines and funding initiatives that prioritise advanced critical care capabilities.
  • The market benefits from the UK's strong healthcare infrastructure and the growing expertise of clinical teams in managing ECMO patients.
  • Private healthcare providers are also contributing to market expansion by investing in ECMO equipment and training.
  • Regulatory support and reimbursement pathways continue to facilitate adoption, ensuring sustained demand through 2030..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The UK ECMO machines market is valued at $18.84 million in 2025 and will reach $24.96 million by 2030 at a 5.8% CAGR.
    • The UK market is driven by increasing adoption in NHS and private critical care settings with strong regulatory support.
    • Technological advancements and rising cardiac and respiratory disease prevalence are key growth catalysts in the UK.
    • The UK's advanced healthcare infrastructure positions it as a mature market with steady expansion through 2030.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    UK ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    UK: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS4.875.055.255.475.75.966.246.554.5
    HOSPITALS19.920.8321.8622.9524.1725.526.9428.535.5
    SPECIALTY CLINICS3.173.263.363.463.583.73.843.993.5
    TOTAL27.9429.1530.4731.8833.4535.1637.0239.065.1

    Target Audience

    • ECMO Equipment Manufacturers : Manufacturers need UK-specific market data to develop localised sales strategies, understand NHS procurement requirements, and identify opportunities for market share growth in critical care segments.
    • Healthcare Distributors and Suppliers : Distributors require detailed market insights to optimise inventory management, negotiate with NHS trusts, and identify emerging demand patterns across UK regions and healthcare facilities.
    • Hospital and NHS Trust Administrators : Hospital leaders need market intelligence to justify ECMO centre investments, benchmark against peer institutions, and plan capital expenditure for critical care infrastructure development.
    • Private Healthcare Operators : Private healthcare providers require competitive market analysis to assess ECMO service viability, differentiate offerings, and identify partnership opportunities with NHS referral networks.
    • Healthcare Investors and Consultants : Investment firms and management consultants need comprehensive UK market data to evaluate acquisition targets, assess growth potential, and develop strategic recommendations for healthcare stakeholders.

    Key Companies in the UK ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • NHS Market Penetration Strategy : Understand the specific adoption patterns and procurement cycles of NHS trusts to develop targeted sales and partnership strategies for ECMO equipment distribution across UK critical care networks.
    • Competitive Landscape Intelligence : Gain insights into the competitive positioning of ECMO manufacturers and suppliers within the UK market, including market share dynamics and differentiation opportunities in the private and public sectors.
    • Regulatory and Reimbursement Pathways : Access detailed analysis of UK regulatory requirements, NICE guidance, and NHS reimbursement models to navigate the approval and funding landscape for ECMO technologies.
    • Investment and Growth Opportunities : Identify high-growth segments and geographic hotspots within the UK where ECMO adoption is accelerating, enabling informed investment decisions and resource allocation.
    • Clinical and Operational Insights : Understand the clinical drivers, hospital capacity constraints, and operational challenges influencing ECMO adoption in UK healthcare settings to inform product development and service offerings.

    Frequently asked questions

    What is the current size of the UK ECMO machines market?

    The UK ECMO machines market is valued at $18.84 million in 2025.

    What is the projected market size for the UK by 2030?

    The UK ECMO machines market is projected to reach $24.96 million by 2030.

    What is the growth rate of the UK ECMO machines market?

    The UK ECMO machines market is expected to grow at a compound annual growth rate of 5.8% from 2025 to 2030.

    What are the main drivers of growth in the UK ECMO market?

    Key drivers include rising prevalence of cardiac and respiratory conditions, technological advancements in ECMO systems, increased ICU investment, and strong regulatory frameworks supporting adoption in the UK.

    Which healthcare settings in the UK are adopting ECMO technology?

    ECMO technology is being adopted across NHS hospitals, private healthcare facilities, major teaching hospitals, and regional cardiac centers throughout the UK.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status